Revista nº 821

COVID-19, co-infecciones y resistencia antimicrobiana | Montoya-Madriz S, et al. 20 Actual Med.2025;110(821):9 -21 11. Nebreda-Mayoral T, Miguel-Gómez MA, March-Rosselló GA, Puente-Fuertes L, Cantón-Benito E, Martínez-García AM, et al. Bacterial/fungal infection in hospitalized pa - tients with COVID-19 in a tertiary hospital in the Commu - nity of Castilla y León, Spain. Enferm Infecc Microbiol Clin. 2022,40(4):158–65. DOI: 10.1016/j.eimce.2022.02.002 12. Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. Geno - mic diversity of severe acute respiratory syndrome-co- ronavirus 2 in patients with coronavirus disease 2019. Clinical Infectious Diseases. 2020;71(15):713–20. DOI: 10.1093/cid/ciaa203 13. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardio - vascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–8. DOI: 10.1001/jamacardio.2020.1017 14. Hanada S, Pirzadeh M, Carver KY, Deng JC. Respira - tory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol. 2018; 9:26409:1–15. DOI: 10.3389/fimmu.2018.02640 15. Molina-Mora JA. Insights into the mutation T1117I in the spike and the lineage B.1.1.389 of SARS-CoV-2 circula - ting in Costa Rica. Gene Rep [Internet]. 2022 [cited 2022 Feb 8];27:1–9. Available from: https://linkinghub.elsevier . com/retrieve/pii/S2452014422000620 DOI: 10.1038/ s41598-022-13113-4 16. Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clini - cal features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. Journal of Clinical Vi - rology [Internet]. 2020;127:104364. DOI: 10.1016/j. jcv.2020.104364 17. Calcagno A, Ghisetti V, Burdino E, Trunfio M, Allice T, Boglione L, et al. Co-infection with other respiratory pathogens in COVID-19 patients. Clinical Microbiolo - gy and Infection. 2021;27(2):297–8. DOI: 10.1016/j. cmi.2020.08.012 18. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clinical Infectious Diseases. 2020;71(15):769–77. DOI: 10.1093/cid/ciaa272 19. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epi - demiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507–13. DOI: 10.1016/S0140-6736(20)30211-7 20. Shafran N, Shafran I, Ben-Zvi H, Sofer S, Sheena L, Krause I, et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients. Nature Portfolio Scientific Reports [Internet]. 2021;11(123):12703. DOI: 10.1038/s41598-021-92220-0 21. Alshaikh FS, Godman B, Sindi ON, Andrew Seaton R, Kur - di A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and metaanalysis. Vol. 17, PLoS ONE. Public Library of Science; 2022. DOI: 10.1371/journal. pone.0272375 22. Goncalves Mendes Neto A, Lo KB, Wattoo A, Salacup G, Pelayo J, DeJoy R, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol. 2021;93(3):1489–95. DOI: 10.1002/jmv.26441 23. Puzniak L, Finelli L, Yu KC, Bauer KA, Moise P, De Anda C, et al. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. BMC Infect Dis. 2021;21(1). DOI: 10.1186/s12879-021-05877-3 24. Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Mada - line T, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2021;42(1):84–8. DOI: 10.1017/ice.2020.368 25. Bhargava A, Riederer K, Sharma M, Fukushima EA, Jo - hnson L, Saravolatz L. High rate of Multidrug-Resistant Organisms (MDROs) among COVID-19 patients pre- senting with bacteremia upon hospital admission. Am J Infect Control. 2021;49(11):1441–2. DOI: 10.1016/j. ajic.2021.08.010 26. Raychaudhuri D, Sarkar M, Roy A, Roy D, Datta K, Sengupta T, et al. COVID-19 and Co-infection in children: The Indian perspectives. Vol. 67, Journal of Tropical Pediatrics. Oxford University Press; 2021. DOI: 10.1093/tropej/fmab073 27. Wu HY, Chang PH, Chen KY, Lin IF, Hsih WH, Tsai WL, et al. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treat- ment. Vol. 55, Journal of Microbiology, Immunology and Infection. Elsevier Ltd; 2022. p. 985–92. DOI: 10.1016/j. jmii.2022.09.006 28. Roh KH, Kim YK, Kim SW, Kang ER, Yang YJ, Jung SK, et al. Coinfections with Respiratory Pathogens among CO - VID-19 Patients in Korea. Canadian Journal of Infectious Diseases and Medical Microbiology. 2021;2021. DOI: 10.1155/2021/6651045 29. WHO. Global Antimicrobial Resistance and Use Survei- llance System (GLASS) Report 2022 [Internet]. Vol. CC BY-NC-SA 3.0 IGO. 2022. Available from: https://www. who.int/publications/book-orders. 30. Bentivegna E, Luciani M, Arcari L, Santino I, Simmaco M, Martelletti P, et al. Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pande - mic: A Retrospective Study. J Environ Res Public Health [Internet]. 2021;18. DOI: 10.3390/ijerph18031003 31. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial anti- microbial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–55. DOI: 10.1016/S0140- 6736(21)02724-0